Variant report
Variant | esv3331954 |
---|---|
Chromosome Location | chr5:1778104-1778603 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:8)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:8 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:1778287..1780769-chr5:1785430..1787749,2 | MCF-7 | breast: | |
2 | chr5:1778219..1779959-chr5:1780959..1783079,2 | K562 | blood: | |
3 | chr5:1777386..1781042-chr5:1781579..1783555,3 | K562 | blood: | |
4 | chr5:1765029..1767933-chr5:1776695..1778793,2 | K562 | blood: | |
5 | chr5:1776964..1780594-chr5:1799950..1802752,5 | K562 | blood: | |
6 | chr5:1777867..1779395-chr5:1796687..1799686,2 | K562 | blood: | |
7 | chr5:1774144..1776349-chr5:1777673..1779525,2 | K562 | blood: | |
8 | chr5:1773229..1775026-chr5:1777658..1779711,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000145494 | chromatin interactions |
ENSG00000171421 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs73022165 | chr5:1778106-1778107 | Weak transcription Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs186759734 | chr5:1778115-1778116 | Weak transcription Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs529882892 | chr5:1778179-1778180 | Weak transcription Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs547932509 | chr5:1778183-1778184 | Weak transcription Bivalent Enhancer Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs372445499 | chr5:1778261-1778262 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs530497157 | chr5:1778267-1778268 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs552229551 | chr5:1778277-1778278 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs73022168 | chr5:1778278-1778279 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs528675213 | chr5:1778290-1778291 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs13186705 | chr5:1778342-1778343 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs370062268 | chr5:1778345-1778346 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs11957851 | chr5:1778380-1778381 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs138028652 | chr5:1778381-1778382 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs371250992 | chr5:1778420-1778421 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs557554532 | chr5:1778425-1778426 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs536115007 | chr5:1778430-1778431 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs551299999 | chr5:1778443-1778444 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs11953809 | chr5:1778464-1778465 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs369115034 | chr5:1778465-1778466 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs11957879 | chr5:1778473-1778474 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs557955756 | chr5:1778474-1778475 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs374608262 | chr5:1778496-1778497 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs540617319 | chr5:1778498-1778499 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs375411414 | chr5:1778504-1778505 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs13187053 | chr5:1778559-1778560 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs373525098 | chr5:1778563-1778564 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs13187184 | chr5:1778593-1778594 | Enhancers Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Biliary cancer | 19435499 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16608533 | CNVD |
Cervical cancer | 16585170 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Lung cancer | 17925434 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 19181860 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Developmental delay | 19490664 | CNVD |
Human papillomavirus | 17975027 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Gastric cancer | 16891809 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Emphysema | 19352772 | CNVD |
Chordoma | 18071362 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 20164919 | CNVD |
Oral cancer | 22144094 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Glioma | 20126413 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:1772400-1788400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr5:1777800-1778600 | Enhancers | Pancreas | Pancrea |
3 | chr5:1777800-1784400 | Weak transcription | Right Atrium | heart |
4 | chr5:1778000-1778200 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin02 | Skin |
5 | chr5:1778000-1779200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr5:1778200-1778600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr5:1778400-1778600 | Enhancers | Fetal Brain Female | brain |
8 | chr5:1778600-1778800 | Bivalent Enhancer | Cortex derived primary cultured neurospheres | brain |
9 | chr5:1778600-1779000 | Weak transcription | Pancreas | Pancrea |